Abstract Background Rates of enrolment in clinical trials in inflammatory bowel disease [IBD] have decreased dramatically in recent years. This has led to delays, increased costs and failures to develop novel treatments. Aims The aim of this work is to describe the current bottlenecks of IBD clinica...
No comments yet
Be the first to share your thoughts!